Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · IEX Real-Time Price · USD
22.57
-0.48 (-2.08%)
At close: Jul 2, 2024, 4:00 PM
22.68
+0.11 (0.49%)
After-hours: Jul 2, 2024, 7:13 PM EDT
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $1.86 billion as of July 2, 2024. Its market cap has decreased by -23.38% in one year.
Market Cap
1.86B
Enterprise Value
924.88M
1-Year Change
-23.38%
Ranking
Category
Stock Price
$22.57
Market Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $849.80M to $1.86B, an increase of 118.61%. That is a compound annual growth rate of 19.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 1.90B | -14.48% |
| Dec 29, 2023 | 2.22B | -19.50% |
| Dec 30, 2022 | 2.76B | -49.24% |
| Dec 31, 2021 | 5.43B | 14.74% |
| Dec 31, 2020 | 4.73B | 456.87% |
| Feb 6, 2020 | 849.80M | - |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Premier | 1.95B |
| Astrana Health | 1.94B |
| LifeStance Health Group | 1.91B |
| Addus HomeCare | 1.90B |
| Kymera Therapeutics | 1.90B |
| Warby Parker | 1.89B |
| Amphastar Pharmaceuticals | 1.88B |
| BrightSpring Health Services | 1.88B |